PATENT CLAIM ANALYSIS

Application Number: 15746404
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["435", "007100"]

Abstract:
The disclosure relates generally to methods of detecting and quantifying methotrexate (MTX) in a sample. The methods disclosed herein decrease cross-reactivity and improve sensitivity of the detection.

Claim (Index 31):
An isolated antibody that binds to methotrexate (MTX), the antibody comprising a variable heavy chain and a variable light chain, wherein the variable heavy chain amino acid sequence comprises SEQ ID NO:11 and wherein the variable light chain amino acid sequence comprises SEQ ID NO:12.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.19231
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12873926', '10280716', '14361731', '13836229', '14843285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.552574272808831
- 35 USC 102 Novelty (BERT): 0.508936923798365
- Combined Prediction Score: 0.5482105379077844
- Mean Citation Score: 253.792926
- Max Citation Score: 284.93808
- Similarity Product: 195.18715407663345

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test